-
Thermo Fisher Continues Expansion to Support COVID-19 Response
contractpharma
July 21, 2020
BARDA provides funding to support the expansion of Thermo Fisher's manufacturing capacity for sterile injectables.
-
VitaDairy - the No. 1 colostrum company in Vietnam help people strengthening the immune system to contribute fighting off COVID-19
prnasia
July 20, 2020
Vietnam has been one of the countries that have well managed COVID-19 pandemic with only 383 cases, and no deaths have been reported (updated on 20th July). Immune Nutrition from ColosIgG 24h colostrum is one of the factors contribute fighting off COVID-1
-
Synairgen's SNG001 shows strong promise in COVID-19 trial
pharmatimes
July 20, 2020
Southampton, UK-based Synairgen has announced positive results from a clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised COVID-19 patients.
-
AGC Biologics, Molecular Partners to Develop Anti-COVID-19 DARPin Program
americanpharmaceuticalreview
July 20, 2020
AGC Biologics is partnering with clinical-stage biotech company Molecular Partners to develop a new class of custom-built protein therapeutics known as DARPin?.
-
CEBINA Identifies Common Antihistamine Nasal Spray as a Potential Anti-COVID-19 Approach
americanpharmaceuticalreview
July 20, 2020
CEBINA GmbH has announced positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays.
-
TXA127 from Constant Therapeutics Tested in COVID-19 Trials
americanpharmaceuticalreview
July 20, 2020
Constant Therapeutics announced its peptide drug TXA127 will be tested in a series of Phase 2 clinical trials in hospitalized COVID-19 patients who are not in the Intensive Care Unit (ICU).
-
Novartis launches not-for-profit COVID-19 medications portfolio
europeanpharmaceuticalreview
July 20, 2020
The portfolio will be offered to low- and lower-middle-income countries to help financially strained healthcare systems care for COVID-19 patients.
-
Tonix to focus on precision medicine approaches for Covid-19
pharmaceutical-technology
July 20, 2020
Tonix Pharmaceuticals has signed a research collaboration and option agreement with Columbia University to explore precision medicine approaches for vaccines and therapeutics against Covid-19.
-
Adagio Therapeutics launches with focus on coronavirus antibodies
pharmaceutical-technology
July 20, 2020
Biotechnology startup Adagio Therapeutics, a spin-out of Adimab, has launched with $50m in Series A funding to support its work on coronavirus antibodies that could prevent and treat Covid-19, as well as any future coronavirus outbreaks.
-
Zydus receives approval from COFEPRIS to conduct clinical trials for COVID-19 treatment therapy
expresspharma
July 20, 2020
Zydus had earlier approached the DCGI to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and the clinical trials are now underway.